Isosorbide Mononitrate
Brand names: Ismo, Imdur, Chemydur 60XL
Isosorbide mononitrate is an oral long-acting nitrate used for the prophylaxis of angina and as an adjunct in chronic heart failure.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is converted to nitric oxide, raising vascular smooth-muscle cyclic GMP to produce predominantly venous dilatation that reduces preload and myocardial oxygen demand.
Prescribing in practice
- A nitrate-free interval each day is needed to prevent tolerance, so dosing is timed to leave a low-nitrate period rather than spread evenly around the clock.
- Contraindicated with phosphodiesterase-5 inhibitors such as sildenafil because of the risk of severe hypotension.
- Use cautiously where preload reduction is harmful, such as hypotension, hypovolaemia or aortic and mitral stenosis, and do not stop abruptly after long-term use.
Monitoring
Monitor for postural hypotension, headache and adequacy of angina control, and ensure the nitrate-free interval is maintained.
Counselling the patient
- Headache is common at first and usually settles; take as prescribed to keep the daily low-nitrate gap.
- It prevents rather than relieves angina attacks, so keep a short-acting nitrate spray for acute symptoms.
Evidence & guidelines
A long-established antianginal supported by extensive clinical experience and reflected in NICE stable angina guidance.
Reference: NICE NG185; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Peripheral Arterial Disease · NICE NG19 2012 / ESVS 2017
- Carotid Artery Disease · NICE CG68 / ESVS 2018
- Varicose Veins Management · NICE CG168 2013
- Venous Leg Ulcer Management · NICE NG204 2022
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185